Mel Spigelman on the future of TB treatment and the evolution of TB AllianceÂ
2025 marks the 25th anniversary of TB Alliance. Throughout the year, we are sitting down with leaders and visionaries in […]
Story
Ariel Pablos-Mendez on the past, present, and future of TB research and the TB Alliance
February 8th marks the 25th anniversary of the signing of the Cape Town Declaration, which birthed TB Alliance. Throughout the
Building the Largest TB Drug Portfolio
TB Alliance has built the largest portfolio of potential new tuberculosis (TB) treatments in history. Since inception, it has introduced
Without Community, Research is Not Possible: Community Engagement in TB Research
When TB Alliance was formed, there had been no late-stage tuberculosis (TB) research trials conducted to modern standards. In addition
At United Nations High Level Meeting, World Leaders Commit to Ending TB
Unfortunately, the recent history of the tuberculosis (TB) pandemic has in large part been defined by neglect—inadequate funding for research
The First Clinical Trial of Multiple New TB Drugs in Combination
TB Alliance has shifted the TB treatment research paradigm from a focus on developing individual drugs to one of developing
Combating the TB Pandemic Amid a New Threat
As TB Alliance acknowledges its 20th year, we remain committed to advancing new cures and meeting the aspirations of those
Marking the Path: Biomarker Research and MARK-TB – An Interview with Riccardo Alagna
Throughout TB Alliance’s history, it has expanded its pursuit and advocacy for various types of TB research, as it identifies
REMox TB Trial Paves the Way for 21st Century TB Drug Trials
In 2008, TB Alliance launched the first Phase 3 clinical trial of a new TB drug in four decades. The
Building Global Capacity for Modern TB Treatment Research
As TB Alliance acknowledges its 20th year, we remain committed to advancing new cures and meeting the aspirations of those